Showing results (51-60 of 64) with videos related to
Sort By:
Pageof 7
Biology of Reproduction|October 20, 2006
Neutralization of endogenous vascular endothelial growth factor depletes primordial follicles in the mouse ovaryAmanda E Roberts, Laura K Arbogast, Chad I Friedman, et al.Biology of Reproduction|December 1, 1987
Identification of gonadotropin surge-inhibiting factor (GnSIF) in follicular fluid and its differentiation from inhibinD R Danforth, M J Sinosich, T L Anderson, et al.Journal of Medical Primatology|January 1, 1989
Gonadotropin-releasing hormone infusion interval: importance in pharmacodynamicsR Schmutzler, K Elkind-Hirsch, D Hahn, et al.Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|April 28, 2011
Using second life virtual simulation environment for mock oral emergency medicine examinationJillian Schwaab, Nicholas Kman, Rollin Nagel, et al.Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|September 10, 2017
Using Virtual Reality Simulation Environments to Assess Competence for Emergency Medicine LearnersJillian L McGrath, Jeffrey M Taekman, Parvati Dev, et al.Fertility and Sterility|July 11, 1998
Dimeric inhibin: a direct marker of ovarian agingD R Danforth, L K Arbogast, J Mroueh, et al.Journal of the Society for Gynecologic Investigation|October 1, 1994
In vivo effects of a potent GnRH antagonist ORG 30850: physiologic evidence that down-regulation of GnRH receptors does not occurK Gordon, R T Scott, R F Williams, et al.Contraception|June 1, 1990
Intermittent GnRH antagonist plus progestin contraception conserving tonic ovarian estrogen secretion and reducing progestin exposureD R Danforth, R F Williams, J G Hsiu, et al.Journal of Medical Primatology|January 1, 1988
Subcutaneous implantable infusion device for chronic intravenous pulsatile gonadotropin-releasing hormone treatmentR Schmutzler, J F van Uem, K Elkind-Hirsch, et al.Fertility and Sterility|July 31, 1999
Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle-stimulating hormoneD B Seifer, R T Scott, P A Bergh, et al.Pageof 7